Immunis Chairman Dr. Hans Keirstead to Present at the Festival of Biologics in Basel

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a private biotech developing innovative cellular secretome therapies for age and disease-related immune decline, is thrilled to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at the prestigious Festival of Biologics in Basel, Switzerland. The Festival of Biologics is a pivotal…
Click here to view original post